Overview

A Study of DSP-7888 in Pediatric Patients With Relapsed or Refractory High Grade Gliomas

Status:
Completed
Trial end date:
2020-01-01
Target enrollment:
Participant gender:
Summary
This is a phase 1/2, uncontrolled, open-label, multicenter study in patients with recurrent and relapsed diffuse intrinsic pontine glioma, glioblastoma, or grade III or IV glioma.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Sumitomo Dainippon Pharma Co., Ltd.